Latest filing published 21 May 2024 for IRLAB Theraoeutics AB, €5,357.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Carola Elisabet Lemne: trading record in brief
All filings by Carola Elisabet Lemne on record concern IRLAB Theraoeutics AB. In total, 5 filings cover trades dated from 25 February 2022 to 21 May 2024.
In open-market terms, that means 3 purchases worth €67k on one side and 2 sales worth €54k on the other. Netting one side against the other leaves €13k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings 1 purchase and no sales.
The median purchase comes to €31k.
The latest filing, published on 21 May 2024, reports an open-market purchase of €5,357 in IRLAB Theraoeutics AB. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Carola Elisabet Lemne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ SEK 15.558.4% of flowAktieISIN SE0012675361FI:csv-f407faad7161fd4e9641Canonical exit: 19 Aug 2024 (T+90)
- 10,000 shares@ SEK 32.9548.8% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-c8d78e386cbf72a9327cCanonical exit: 26 May 2022 (T+90)
- 9,000 shares@ SEK 32.1042.8% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-244a4d85ca780f1ad116
3 of 3 declarations